Noatum to acquire fully electric Artemis EF-12 Pilot boat
This initiative aligns with the United Nations' Sustainable Development Goals and the UAE's commitment to achieving net zero emissions by 2050.
The Artemis EF-12 is designed with advanced battery technology that enables zero-emission propulsion, making it suitable for sustainable operations.
The vessel can reach speeds of up to 30kt and maintain a cruising speed of 25kt. It is designed to carry up to four passengers and has a foiling range of 47nm.
The incorporation of Artemis' eFoiler technology allows the boat to lift its hull above the water, which reduces drag and optimises energy consumption while producing minimal wake.
Artemis Technologies CEO Dr Iain Percy said: 'We are proud to support Noatum Maritime in their continued efforts to bring sustainable maritime solutions to the Middle East.
'The acquisition of the Artemis EF-12 Pilot boat marks a significant milestone in addressing the region's growing demand for high-performance, zero operational emission vessels.'
Artemis tested and validated the Artemis EF-12 Pilot simulations using the Artemis EF-12 Workboat, with assistance from the Port of Cork and Cork Pilots in Cork Harbour.
The company completed 15 ship contacts with four vessel types, ranging from 90m to 158m. This testing is essential for optimising the Artemis EF-12 Pilot boat for safe pilot operations, according to the company.
In February this year, Red Funnel and Artemis entered the construction and delivery phase for their next-generation electric ferry for Isle of Wight services, following the finalisation of initial agreements in July 2024.
"Noatum to acquire fully electric Artemis EF-12 Pilot boat" was originally created and published by Ship Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
5 hours ago
- Business Insider
US approves potential $346 million sale of munitions, bombs and rockets to Nigeria
The Pentagon said that the U.S. State Department has approved possible sales of munitions, precision-guided bombs, and rockets to Nigeria, valued at an estimated $346 million. The U.S. State Department approved proposed sales of munitions and precision-guided bombs to Nigeria worth $346 million. The deal includes FMU-139 fuzes, bomb components, rockets, and various support services. Contracts for this sale will be managed by major defence companies like Lockheed Martin, RTX Missiles and Defence, and BAE Systems. The Pentagon said on Wednesday that the U.S. State Department has approved possible sales of munitions, precision-guided bombs, and rockets to Nigeria, valued at an estimated $346 million. The Defence Security Cooperation Agency (DSCA) said Nigeria has requested to purchase: 1,002 MK-82 general-purpose 500 lb bombs 1,002 MXU-650 Air Foil Groups (AFGs) for 500 lb Paveway II GBU-12 515 MXU-1006 AFGs for 250 lb Paveway II GBU-58 1,517 MAU-169 or MAU-209 computer control groups for Paveway II GBU-12/GBU-58 1,002 FMU-152 joint programmable fuzes 5,000 Advanced Precision Kill Weapon System II (APKWS II) all-up rounds, each consisting of a WGU-59/B guidance section, high-explosive warhead, and MK66-4 rocket motor. The package also includes non-major defence equipment (non-MDE) such as FMU-139 joint programmable fuzes, bomb components, impulse cartridges, high-explosive and practice rockets, integration support, and test equipment, along with U.S. government and contractor-provided technical, engineering, and logistics services. Key contractors in the deal According to the statement, the contracts will be executed by Lockheed Martin, RTX Missiles and Defence, and BAE Systems. Lockheed Martin is renowned for its advanced autonomous systems, aircraft, missiles, space launchers, and integrated defence solutions. RTX, the world's second-largest military company by revenue, produces aircraft engines, guided missiles, air defence systems, radars, and cybersecurity technologies. BAE Systems plc, headquartered in London, is the largest defence contractor in Europe and ranks among the leading global defence companies.
Business Wire
2 days ago
- Business Wire
Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors
EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Dr. Reginald Seeto and William S. Solari III to its Board of Directors. "Their guidance will be instrumental as we advance key clinical milestones and unlock the full potential of our pipeline," said Cheng Liu, Ph.D., Founder and CEO of Eureka Therapeutics. Dr. Seeto is a global leader in biopharmaceuticals and diagnostics with expertise in corporate strategy, business development, and operations. He currently serves as President and CEO of Scipher Medicine. Previously, he was President and CEO of CareDx, Inc., guiding the company through a period of rapid growth. He served as Chief Operating Officer at Ardelyx, where he built international partnerships to support commercialization, and held senior leadership roles at AstraZeneca, where he completed over 100 biologics transactions and managed portfolio strategy for more than 150 assets. His earlier career includes McKinsey & Company, Boehringer Ingelheim, and Organon. Mr. Solari brings over 30 years of legal and financial experience in corporate governance, mergers and acquisitions, and complex tax structuring. He was a partner at Jeffer Mangels Butler & Mitchell LLP before founding his own law practice, where he continues to advise clients across diverse industries. 'Reg and Bill bring exceptional leadership and strategic insight to our Board,' said Cheng Liu, Ph.D., Founder and CEO of Eureka Therapeutics. 'Their guidance will be instrumental as we advance key clinical milestones and unlock the full potential of our pipeline.' ABOUT EUREKA THERAPEUTICS, INC. Eureka's proprietary ARTEMIS ® CAR-T platform is designed to overcome key limitations of conventional CAR-T therapies by reducing toxicity to enable higher doses and repeat infusions, improving T-cell persistence for longer-lasting responses, and enhancing tumor infiltration to achieve more potent anti-tumor activity. Eureka's pipeline includes ET140203 (ARYA-2) for pediatric patients and ECT204 (ARYA-3) for adults, both in Phase I/II clinical trials for advanced liver cancer. Eureka Therapeutics, Inc. is headquartered in the San Francisco Bay Area. For more information, please visit
Yahoo
3 days ago
- Yahoo
Do NuScale Power and Oklo Have a New Opportunity That's Out of This World?
Key Points NASA has ambitions to deploy a nuclear reactor on the Moon by 2030. NuScale Power and Oklo are two leading designers of small modular reactors. But some privately held companies may be better suited to win NASA's approval. 10 stocks we like better than NuScale Power › With few exceptions, nuclear energy stocks have provided stellar returns in 2025. From new collaborations that small modular reactor (SMR) makers like NuScale Power (NYSE: SMR) and Oklo (NYSE: OKLO) are announcing to President Donald Trump's executive orders meant to advance development of the nuclear industry, investors have been charged up about the prospects of nuclear energy stocks. But a new opportunity for SMR makers has emerged recently that investors will want to familiarize themselves with sooner rather than later. NASA is charged up about its prospects on the moon At a recent press conference, Sean Duffy, Secretary of the Department of Transportation and acting National Aeronautics and Space Administration (NASA) administrator, stated that one of the space agency's goals is to deploy a 100-kilowatt nuclear reactor on the Moon by 2030 as part of the Artemis program. Scheduled to launch in 2027, Artemis 3 intends to return humans to the lunar surface, where they will perform science activities for six days and then return to Earth. Subsequent to the successful completion of Artemis 3, NASA intends to start sending assets to the lunar surface in preparation for the United States establishing a longer-term human presence. Although Duffy didn't identify the nuclear technology by name, SMRs are ideally suited for the plan to deploy a 100-kilowatt fission reactor that he identified during the press conference. Who could be the winners from the lunar-based ambition for nuclear deployment? Currently, there are no SMRs in operation; however, NuScale Power and Oklo are two companies at the forefront of developing the technology, making them potential candidates to benefit from NASA's goal of deploying a nuclear fission reactor on the moon. NuScale Power has two SMR designs -- a 50 megawatt-electric (MWe) and a 77 MWe -- approved by the U.S. Nuclear Regulatory Commission. The company's SMRs can also be scaled in various configurations up to 924 MWe. Oklo, on the other hand, is designing SMRs, dubbed Aurora powerhouses, that are able to produce 15 MWe to 75 MWe. Since the NRC rejected Oklo's design application for its Aurora powerhouses in 2022, the company has been working to complete a new application, addressing the missing information that the NRC had identified. But it's critical for investors to also recognize that there are other companies that will likely be vying for the contract from NASA. One company that seems particularly well suited for the mission is Radiant, a privately held company that's also committed to developing SMR technology. Unlike NuScale Power and Oklo, Radiant's Kaleidos reactor is designed to be considerably smaller: 1 MWe. In fact, Radiant advertises the Kaleidos reactor as a replacement for diesel generators. Typically, diesel generators produce around 1,000 kilowatts to 3,000 kilowatts, so the Kaleidos reactor seems like a more desirable configuration than the SMRs that NuScale Power and Oklo are currently designing. Another potential contender is X-Energy. Like Radiant, X-Energy is privately held, so nuclear energy investors may be less familiar with the company than its publicly held brethren. X-Energy is currently developing an 80-MWe SMR that can also be scaled into various configurations. Should investors be supercharged about NASA's plans? While NASA's plans to deploy a nuclear reactor on the Moon by 2030 may excite the imaginations of space enthusiasts, the reality is that the plan seems incredibly ambitious. However, if we assume that NASA succeeds in adhering to its timeline -- a considerable assumption -- it's not a certainty that NuScale Power or Oklo will receive the thumbs-up from NASA to supply the necessary equipment. Add to the fact that Radiant, X-Energy, and other companies will be motivated to compete for the opportunity to deploy a nuclear reactor on the Moon, and investors would be unwise to power their portfolios with NuScale Power or Oklo solely based on the presumption that they will benefit from NASA's plan. This is not to say that NuScale Power and Oklo should be completely dismissed. Both companies are well worth further investigation from nuclear energy-focused investors for reasons that transcend NASA's lunar ambition. Should you invest $1,000 in NuScale Power right now? Before you buy stock in NuScale Power, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and NuScale Power wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Scott Levine has no position in any of the stocks mentioned. The Motley Fool recommends NuScale Power. The Motley Fool has a disclosure policy. Do NuScale Power and Oklo Have a New Opportunity That's Out of This World? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
